Results 131 to 140 of about 134,363 (333)

The outcomes of electronic personal health records in patients with heart failure or coronary artery disease

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1464-1468, April 2025.
Abstract Background There are limited data on the efficacy of smartphone‐based personal health records (PHRs) in patients with cardiovascular disease. This study aimed to examine the processes, outcomes and challenges associated with the implementation of integrated PHRs in patients with heart failure (HF) or coronary artery disease (CAD). Methods This
Kotaro Nochioka   +16 more
wiley   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro   +15 more
wiley   +1 more source

A Differentiated Approach to the Assessment of Biomarkers Depending on the Phenotype of Heart Failure

open access: yesУкраїнський журнал серцево-судинної хірургії
Heart failure (HF) remains a major cause of hospitalization and mortality globally. Current evidence suggests significant differences in cardiovascular outcomes based on ejection fraction (EF) phenotypes, including HF with reduced (HFrEF), mildly reduced
Nadiia M. Kulaiets
doaj  

Plasma N‐terminal pro BNP and cardiotrophin‐1 are elevated in aortic stenosis [PDF]

open access: bronze, 2001
Suneel Talwar   +5 more
openalex   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo   +7 more
wiley   +1 more source

Taraxacum Officinale (Dandelion) Roots Extract Mitigates Doxorubicin-Induced HematoCardiotoxicity in Male Albino Rats

open access: yesJournal of Veterinary Medical Research, 2019
The present study was designed to evaluate the probable ameliorative effect of dandelion extract against doxorubicin hemato-cardiotoxicity. To accomplish this study, four groups of male albino rats (n=7) were used as follow, Group I: served as a ...
Dina R. S. Gad El-Karim
doaj  

Home - About - Disclaimer - Privacy